An observational study in Coronary Artery Disease, Valvular Diseases and Vascular Diseases, sponsored by University of California, Davis. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-14.
Sponsored by University of California, Davis · Observational
Among 1,105 studies in Coronary Artery Disease with a site in United States — 102 open to participants now, 147 under way, 10 of them phase 3. Coronary Artery Disease · United States.
Among the 1,105 studies in Coronary Artery Disease with a site in United States, this one is the 25th largest by planned enrollment of the 357 observational ones, is one of 60 that started in 2013, is one of 358 observational ones, reaches primary completion later than 43 of the 144 other live ones, and was the 593rd registered.
4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.
This study's planned enrollment of 5,000 is above the median of 320 across 1,687 observational studies indexed under Coronary Artery Disease.
Browse Coronary Artery Disease studies →102 of the 1,105 studies in Coronary Artery Disease with a site in United States are open now, in 12 countries. Each count lists the studies.
Of the 588 Coronary Artery Disease studies recruiting now, 402 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 38 take children under 18; 47 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →1,105 studies; the count open now beside each. This study's row is marked.
First in 1985; this study’s year is marked. 60 started in 2013.
Median enrollment 107 across the 746 interventional studies, 186 across the 357 observational. Of the 838 that completed or were terminated, 355 (42%) have results posted.
378 of 1,105 have an industry lead sponsor. The 10 most frequent:
University of California, Davis is the lead sponsor of 809 studies on the registry; 142 are open to participants now.
Of its 67 completed or terminated interventional studies of FDA-regulated products, 43 (64%) have results posted.
University of California, Davis has 3 studies filed under Coronary Artery Disease — fewer than ten, so there is no comparison to draw.
53 of the studies in Coronary Artery Disease with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07357675Phase 3EBI Anti Sepsis BVA Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery. | 2027-10-01 |
| NCT06305559Phase 3NewAmsterdam PharmaA CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque | 2027-11 |
| NCT01114269Brigham and Women's HospitalPRE-DETERMINE Cohort Study | 2026-11 |
| NCT06821191University of FloridaComparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study | 2026-11-01 |
| NCT06713239Cleerly, Inc.A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD | 2026-12 |
Among the 1,105 studies in Coronary Artery Disease with a site in United States, from their registry updates:
Identify factors that contribute to perioperative morbidity and mortality in patients undergoing cardiac surgery that involves cardiopulmonary bypass.
Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.
Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.
Here are some examples, but may not limited the following factors:
patients undergoing cardiovascular surgeries
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients greater than or equal to 18 years old that underwent cardiovascular surgery at UC Davis Medical Center from 01/01/2001 to 07/15/2013.
Patients will only be included that underwent cardiovascular surgeries with or without cardiopulmonary bypass.
Exclusion Criteria:
Patients that did not undergo cardiovascular surgeries and age\< 18 years old will be excluded from the study.
all cause mortality
in hospital, 30 day, one year and longer
Time frame: 12 years
The record gives a start of Jul 2013, a primary completion of Dec 2026 and a completion of Dec 2026. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Davis →